R01 HL123326/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2016	3
2017	2
2018	1
2019	1
2020	9
2022	1
2024	0

1

In Vivo Hematopoietic Stem Cell Transduction.

Richter M, Stone D, Miao C, Humbert O, Kiem HP, Papayannopoulou T, Lieber A. Richter M, et al. Hematol Oncol Clin North Am. 2017 Oct;31(5):771-785. doi: 10.1016/j.hoc.2017.06.001. Hematol Oncol Clin North Am. 2017. PMID: 28895846 Free PMC article. Review.

2

Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors.

Miao CH. Miao CH. Thromb J. 2016 Oct 4;14(Suppl 1):41. doi: 10.1186/s12959-016-0105-1. eCollection 2016. Thromb J. 2016. PMID: 27766066 Free PMC article. Review.

3

Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII.

Qu J, Ma C, Xu XQ, Xiao M, Zhang J, Li D, Liu D, Konkle BA, Miao CH, Li L, Xiao W. Qu J, et al. PLoS One. 2020 May 22;15(5):e0233576. doi: 10.1371/journal.pone.0233576. eCollection 2020. PLoS One. 2020. PMID: 32442215 Free PMC article.

4

Comprehensive N- and O-glycosylation mapping of human coagulation factor V.

Ma C, Liu D, Li D, Zhang J, Xu XQ, Zhu H, Wan XF, Miao CH, Konkle BA, Onigman P, Xiao W, Li L. Ma C, et al. J Thromb Haemost. 2020 Aug;18(8):1884-1892. doi: 10.1111/jth.14861. Epub 2020 Jun 14. J Thromb Haemost. 2020. PMID: 32310329 Free PMC article.

5

Strategies to target long-lived plasma cells for treating hemophilia A inhibitors.

Liu CL, Lyle MJ, Shin SC, Miao CH. Liu CL, et al. Cell Immunol. 2016 Mar;301:65-73. doi: 10.1016/j.cellimm.2016.01.005. Epub 2016 Jan 18. Cell Immunol. 2016. PMID: 26877251 Free PMC article.

6

Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles.

Chen CY, Tran DM, Cavedon A, Cai X, Rajendran R, Lyle MJ, Martini PGV, Miao CH. Chen CY, et al. Mol Ther Nucleic Acids. 2020 Jun 5;20:534-544. doi: 10.1016/j.omtn.2020.03.015. Epub 2020 Apr 7. Mol Ther Nucleic Acids. 2020. PMID: 32330871 Free PMC article.

7

Enhancing therapeutic efficacy of in vivo platelet-targeted gene therapy in hemophilia A mice.

Wang X, Fu RY, Li C, Chen CY, Firrman J, Konkle BA, Zhang J, Li L, Xiao W, Poncz M, Miao CH. Wang X, et al. Blood Adv. 2020 Nov 24;4(22):5722-5734. doi: 10.1182/bloodadvances.2020002479. Blood Adv. 2020. PMID: 33216891 Free PMC article.

8

Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice.

Joo JH, Wang X, Singh S, Chen CY, Li C, Adair JE, Kiem HP, Rawlings DJ, Miao CH. Joo JH, et al. Blood Adv. 2022 Oct 11;6(19):5556-5569. doi: 10.1182/bloodadvances.2022008079. Blood Adv. 2022. PMID: 35849710 Free PMC article.

9

CD4⁺ T cells engineered with FVIII-CAR and murine Foxp3 suppress anti-factor VIII immune responses in hemophilia a mice.

Fu RY, Chen AC, Lyle MJ, Chen CY, Liu CL, Miao CH. Fu RY, et al. Cell Immunol. 2020 Dec;358:104216. doi: 10.1016/j.cellimm.2020.104216. Epub 2020 Sep 16. Cell Immunol. 2020. PMID: 32987195 Free PMC article.

10

Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII.

Firrman J, Wang Q, Wu W, Dong B, Cao W, Moore AR, Roberts S, Konkle BA, Miao C, Liu L, Li D, Xiao W. Firrman J, et al. Mol Ther Methods Clin Dev. 2020 Jan 15;17:328-336. doi: 10.1016/j.omtm.2019.12.019. eCollection 2020 Jun 12. Mol Ther Methods Clin Dev. 2020. PMID: 32071925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year